Fibrosing colonopathy in children with cystic fibrosis.
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003106:Colon / Q000473:pathology*; D003550:Cystic Fibrosis / Q000473:pathology*; D005260:Female; D005355:Fibrosis; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007415:Intestinal Obstruction / Q000209:etiology; D008049:Lipase / Q000009:adverse effects; D008297:Male; D010184:Pancreatic Extracts / Q000009:adverse effects; D010194:Pancreatin / Q000009:adverse effects* / Q000627:therapeutic use; D020799:Pancrelipase
D010184:Pancreatic Extracts; D020799:Pancrelipase; D010194:Pancreatin; D008049:Lipase